UniProt ID | HSF2_HUMAN | |
---|---|---|
UniProt AC | Q03933 | |
Protein Name | Heat shock factor protein 2 | |
Gene Name | HSF2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 536 | |
Subcellular Localization | Cytoplasm . Nucleus . Cytoplasmic during normal growth and moves to the nucleus upon activation. | |
Protein Description | DNA-binding protein that specifically binds heat shock promoter elements (HSE) and activates transcription. In higher eukaryotes, HSF is unable to bind to the HSE unless the cells are heat shocked.. | |
Protein Sequence | MKQSSNVPAFLSKLWTLVEETHTNEFITWSQNGQSFLVLDEQRFAKEILPKYFKHNNMASFVRQLNMYGFRKVVHIDSGIVKQERDGPVEFQHPYFKQGQDDLLENIKRKVSSSKPEENKIRQEDLTKIISSAQKVQIKQETIESRLSELKSENESLWKEVSELRAKHAQQQQVIRKIVQFIVTLVQNNQLVSLKRKRPLLLNTNGAQKKNLFQHIVKEPTDNHHHKVPHSRTEGLKPRERISDDIIIYDVTDDNADEENIPVIPETNEDVISDPSNCSQYPDIVIVEDDNEDEYAPVIQSGEQNEPARESLSSGSDGSSPLMSSAVQLNGSSSLTSEDPVTMMDSILNDNINLLGKVELLDYLDSIDCSLEDFQAMLSGRQFSIDPDLLVDLFTSSVQMNPTDYINNTKSENKGLETTKNNVVQPVSEEGRKSKSKPDKQLIQYTAFPLLAFLDGNPASSVEQASTTASSEVLSSVDKPIEVDELLDSSLDPEPTQSKLVRLEPLTEAEASEATLFYLCELAPAPLDSDMPLLDS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Sumoylation | ------MKQSSNVPA ------CCCCCCHHH | 59.91 | 28112733 | |
51 | Ubiquitination | FAKEILPKYFKHNNM HHHHHHHHHHCCCCH | 60.93 | 21890473 | |
51 | Ubiquitination | FAKEILPKYFKHNNM HHHHHHHHHHCCCCH | 60.93 | 21890473 | |
51 | Ubiquitination | FAKEILPKYFKHNNM HHHHHHHHHHCCCCH | 60.93 | 21890473 | |
54 | Ubiquitination | EILPKYFKHNNMASF HHHHHHHCCCCHHHH | 42.19 | 21890473 | |
54 | Ubiquitination | EILPKYFKHNNMASF HHHHHHHCCCCHHHH | 42.19 | 21890473 | |
54 | Ubiquitination | EILPKYFKHNNMASF HHHHHHHCCCCHHHH | 42.19 | 21890473 | |
54 | Malonylation | EILPKYFKHNNMASF HHHHHHHCCCCHHHH | 42.19 | 26320211 | |
82 | Sumoylation | HIDSGIVKQERDGPV EECCCCCCCCCCCCC | 44.51 | - | |
82 | Ubiquitination | HIDSGIVKQERDGPV EECCCCCCCCCCCCC | 44.51 | - | |
82 | Sumoylation | HIDSGIVKQERDGPV EECCCCCCCCCCCCC | 44.51 | 16428449 | |
97 | Ubiquitination | EFQHPYFKQGQDDLL CCCCCHHHCCCHHHH | 47.91 | - | |
108 | Ubiquitination | DDLLENIKRKVSSSK HHHHHHHHHHHHCCC | 58.72 | - | |
110 | Ubiquitination | LLENIKRKVSSSKPE HHHHHHHHHHCCCCC | 41.28 | - | |
128 | Ubiquitination | IRQEDLTKIISSAQK CCHHHHHHHHHHHHH | 45.39 | - | |
135 | Ubiquitination | KIISSAQKVQIKQET HHHHHHHHHHHCHHH | 35.50 | - | |
135 | Sumoylation | KIISSAQKVQIKQET HHHHHHHHHHHCHHH | 35.50 | 28112733 | |
135 | Acetylation | KIISSAQKVQIKQET HHHHHHHHHHHCHHH | 35.50 | 25953088 | |
135 | Sumoylation | KIISSAQKVQIKQET HHHHHHHHHHHCHHH | 35.50 | - | |
139 | Sumoylation | SAQKVQIKQETIESR HHHHHHHCHHHHHHH | 25.62 | 16428449 | |
139 | Sumoylation | SAQKVQIKQETIESR HHHHHHHCHHHHHHH | 25.62 | - | |
139 | Ubiquitination | SAQKVQIKQETIESR HHHHHHHCHHHHHHH | 25.62 | - | |
142 | Phosphorylation | KVQIKQETIESRLSE HHHHCHHHHHHHHHH | 27.79 | - | |
151 | Sumoylation | ESRLSELKSENESLW HHHHHHHHHHCHHHH | 52.23 | 28112733 | |
151 | Sumoylation | ESRLSELKSENESLW HHHHHHHHHHCHHHH | 52.23 | - | |
151 | Ubiquitination | ESRLSELKSENESLW HHHHHHHHHHCHHHH | 52.23 | 21906983 | |
159 | Ubiquitination | SENESLWKEVSELRA HHCHHHHHHHHHHHH | 54.23 | - | |
167 | Ubiquitination | EVSELRAKHAQQQQV HHHHHHHHHHHHHHH | 32.79 | - | |
197 | Ubiquitination | QLVSLKRKRPLLLNT CEECEECCCCEEECC | 57.70 | - | |
210 | Ubiquitination | NTNGAQKKNLFQHIV CCCCHHHCCHHHHHH | 46.96 | 21890473 | |
210 | Ubiquitination | NTNGAQKKNLFQHIV CCCCHHHCCHHHHHH | 46.96 | 21890473 | |
210 | Sumoylation | NTNGAQKKNLFQHIV CCCCHHHCCHHHHHH | 46.96 | 28112733 | |
210 | Ubiquitination | NTNGAQKKNLFQHIV CCCCHHHCCHHHHHH | 46.96 | 21890473 | |
218 | Sumoylation | NLFQHIVKEPTDNHH CHHHHHHCCCCCCCC | 58.32 | 28112733 | |
237 | Sumoylation | HSRTEGLKPRERISD CCCCCCCCCHHHCCC | 53.54 | 28112733 | |
237 | Acetylation | HSRTEGLKPRERISD CCCCCCCCCHHHCCC | 53.54 | 25953088 | |
384 (in isoform 2) | Phosphorylation | - | 20.11 | 28634120 | |
384 | Phosphorylation | MLSGRQFSIDPDLLV HHHCCCEECCHHHHH | 20.11 | 27251275 | |
420 | Ubiquitination | NKGLETTKNNVVQPV CCCCCCCCCCEEECC | 54.68 | 2190698 | |
489 | Phosphorylation | EVDELLDSSLDPEPT EHHHHHHCCCCCCCC | 32.54 | 26074081 | |
490 | Phosphorylation | VDELLDSSLDPEPTQ HHHHHHCCCCCCCCC | 36.14 | 26074081 | |
496 | Phosphorylation | SSLDPEPTQSKLVRL CCCCCCCCCHHHEEE | 43.76 | 26074081 | |
498 | Phosphorylation | LDPEPTQSKLVRLEP CCCCCCCHHHEEEEE | 30.36 | 26074081 | |
507 | Phosphorylation | LVRLEPLTEAEASEA HEEEEECCHHHCCHH | 43.81 | 26074081 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of HSF2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HSF2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HSF2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...